Antibody-drug conjugates (ADCs) represent a promising advancement in the fight against cancer. ADCs integrate the targeting ability of antibodies with the potent power of cytotoxic drugs. By transporting these potent agents directly to cancer cells, ADCs amplify treatment efficacy while limiting